Autoantibodies in Sjögren's Syndrome

Rheum Dis Clin North Am. 2016 Aug;42(3):419-34. doi: 10.1016/j.rdc.2016.03.002. Epub 2016 Jun 21.

Abstract

We compiled information on antibodies in Sjögren syndrome, focusing more on clinical manifestations associated with anti-Ro/SSA and anti-La/SSB antibodies and studies regarding novel antibodies. We reviewed previous as well as most recent studies with the subject heading Sjogren in combination with antibodies and congenital heart block (CHB). Almost half of asymptomatic mothers giving birth to children with CHB ultimately develop Sjögren. We discussed studies concerning the presence of antibodies predating clinical manifestations of disease. Studies in the future are required to ascertain the pathogenic mechanisms associated with these antibodies and the specific clinical manifestation related to new autoantibodies.

Keywords: Autoantibodies; Congenital heart block; Sjögren’s syndrome.

Publication types

  • Review

MeSH terms

  • Antibodies, Antinuclear / immunology
  • Autoantibodies / immunology*
  • Autoantibodies / metabolism
  • Disease Progression
  • Female
  • Heart Block / congenital
  • Heart Block / immunology
  • Humans
  • Infant, Newborn
  • Lupus Erythematosus, Systemic / congenital
  • Lupus Erythematosus, Systemic / immunology
  • Peptides, Cyclic / immunology
  • Pregnancy
  • Receptor, Muscarinic M3 / immunology
  • Rheumatoid Factor / immunology
  • Sjogren's Syndrome / immunology*

Substances

  • Antibodies, Antinuclear
  • Autoantibodies
  • Peptides, Cyclic
  • Receptor, Muscarinic M3
  • SS-A antibodies
  • SS-B antibodies
  • anticentromere antibody
  • cyclic citrullinated peptide
  • Rheumatoid Factor

Supplementary concepts

  • Congenital heart block
  • Neonatal Systemic lupus erythematosus